CHAPEL HILL, NC, UNITED STATES - Mar 3, 2015 -
WHAT: Rho, a full-service contract research
organization (CRO), will provide valuable insight and important
considerations for adopting the recent Food and Drug Administration
(FDA) Guidance, Providing Regulatory Submissions in Electronic
Format - Standardized Study Data, through a free webinar.
Understanding these guidelines is paramount to the success and
efficiency of a trial, as submissions that are not electronic or in
the appropriate format will not be filed.
During the webinar, Rhos Rob
Woolson, chief strategist, Biostatistics and Data Standards for
Regulatory Submissions, and Ben Vaughn, senior statistical
scientist, will review key points in the FDA guidance, followed by
a discussion of the implications for sponsors currently conducting
studies and those who will be starting new studies
soon.
WHO: Rob Woolson and Ben Vaughn
WHEN: Thursday, March 12, 2015
1:00 p.m. ET/ 10
a.m. PT
Duration:
60 minutes
Webinar Registration:http://www.fiercepharma.com/offer/rho_march2015?source=Rho
DETAILS: For media inquiries, please
contact Bernadette Miller at Largemouth Communications, (703) 297-5992,bernadette@largemouthpr.com.
ABOUT: Rho, a privately-held, contract
research organization (CRO) located in Chapel Hill, NC, provides a
full range of clinical research services across the entire drug
development process. For 31 years, Rho has been a trusted partner
to some of the industrys leading pharmaceutical, biotechnology,
and medical device companies as well as academic and government
organizations. Our commitment to excellence, our innovative
technologies, and our therapeutic expertise accelerate time to
market, maximize returns on investment, and lead to an exceptional
customer experience. For more information, please visit www.rhoworld.com and follow us
on Twitter.